What AI says about CVSP-AIE

Part of Mwxiao

Data as of Oct 20, 2026Based on 38,107 AI responsesReviewed by

How we measure

mwxiao.com

CVSP-AIE is an AI-powered virtual screening platform that integrates three docking and re-scoring models—KarmaDock for efficient large-library ligand docking, CarsiDock for accurate protein-ligand docking, and RTMscore, a residue-atom distance likelihood potential-based scoring function using graph transformers. It enables structure-based drug discovery by enabling hierarchical virtual screening and improved docking pose prediction across large compound libraries. It is developed by HouLab at Zhejiang University's College of Pharmaceutical Sciences.

Mwxiao<1%

Products

  • CVSP-AIEThis page<1%
Mentioned in

<1%

across CVSP-AIE’s markets · since Jul 5

Where AI mentions CVSP-AIE

Each engine’s share of its own answers across CVSP-AIE’s markets · since Jul 5

  • ChatGPT Search<1%
  • Google AI Mode0%

Questions and answers

Sources AI cites

mwxiao.com 0%Other sites 100%